Telemetry Investments’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Telemetry Investments’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-80,000	Closed	-$136K	–	154
2018 Q3	$136K	Buy	+80,000	New	+$143K	0.06%	106
2016 Q2	–	Sell	-95,200	Closed	-$263K	–	129
2016 Q1	$263K	Buy	95,200 +38,900	+69%	+$141K	0.08%	79
2015 Q4	$319K	Sell	56,300 -83,700	-60%	-$510K	0.11%	96
2015 Q3	$742K	Buy	+140,000	New	+$1.08M	0.32%	65

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Telemetry Investments's SGYP Position: Q4 2018 in Review

Telemetry Investments sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 80,000 shares — an estimated $136K sold.

Telemetry Investments first reported a position in SGYP in Q3 2015 and held it in 4 quarters. The position peaked at $742K in Q3 2015. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Telemetry Investments reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Telemetry Investments sold 80,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $136K.
Telemetry Investments first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 4 quarters.
Telemetry Investments's Synergy Pharmaceuticals, Inc Common Stock position peaked at $742K in Q3 2015.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Telemetry Investments's 13F filing for Q4 2018, filed 14 Feb 2019.